ANDA 65485, held by Barr Laboratories. Minocycline Hydrochloride.
As of Nov 22, 2026, ANDA 65485 (Minocycline Hydrochloride), held by Barr Laboratories, was first approved by FDA on Mar 17, 2009, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 17, 2009 | Original application | Approved | None posted |
| Minocycline HydrochlorideEQ 45MG BASE · tablet, extended release;oral | Minocycline Hydrochloride | Discontinued |
| Minocycline HydrochlorideEQ 90MG BASE · tablet, extended release;oral | Minocycline Hydrochloride | Discontinued |
| Minocycline HydrochlorideEQ 135MG BASE · tablet, extended release;oral | Minocycline Hydrochloride | Discontinued |
| Minocycline HydrochlorideEQ 65MG BASE · tablet, extended release;oral | Minocycline Hydrochloride | Discontinued |
| Minocycline HydrochlorideEQ 115MG BASE · tablet, extended release;oral | Minocycline Hydrochloride | Discontinued |
| Minocycline HydrochlorideEQ 80MG BASE · tablet, extended release;oral | Minocycline Hydrochloride | Discontinued |
| Minocycline HydrochlorideEQ 105MG BASE · tablet, extended release;oral | Minocycline Hydrochloride | Discontinued |
| Mar 31, 2025 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jun 28, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Apr 26, 2017 | Supplement 5Manufacturing | Approved | |
| Apr 26, 2017 | Supplement 8Manufacturing | Approved | |
| Nov 26, 2014 | Supplement 7Labeling · Standard review | Approved | None posted |
| May 18, 2012 | Supplement 4 | Approved | |
| Nov 14, 2011 | Supplement 6Labeling | Approved | None posted |
| Mar 17, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters